Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

S6 kinase 2 potentiates interleukin-3-driven cell proliferation.

Rebecca Cruz1, Lee Hedden, Derek Boyer

  • 1Department of Biological Sciences, California State University at Long Beach, 1250 Bellflower Blvd., Long Beach, CA 90840, USA.

Journal of Leukocyte Biology
|October 6, 2005
PubMed
Summary

Interleukin-3 (IL-3) signaling activates S6 kinase 2 (S6K2) via the PI-3K/mTOR pathway, promoting hematopoietic cell proliferation. S6K2 accelerates cell cycle entry, highlighting its role in IL-3-mediated growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-enzymatic RNA Glycation is a Metabolic Sensor of Cellular Stress.

bioRxiv : the preprint server for biology·2026
Same author

A Legacy of Mentorship: A Tribute to Lewis Cantley.

Cancer discovery·2026
Same author

Crip2 preserves hematopoietic stem and progenitor cell production through inhibition of Notch signals.

Development (Cambridge, England)·2026
Same author

Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation.

Science (New York, N.Y.)·2026
Same author

N<sup>6</sup>-Methyladenosine: an RNA modification as a central regulator of cancer.

Nature reviews. Cancer·2025
Same author

pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication.

Cell·2025

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Interleukin-3 (IL-3) is crucial for hematopoietic cell survival and proliferation.
  • IL-3 signaling involves pathways like PI-3K/mTOR, impacting hematopoiesis and immune function.
  • The role of mTOR downstream targets, such as S6 kinase 2 (S6K2), in IL-3 signaling requires further elucidation.

Purpose of the Study:

  • To investigate the role of S6 kinase 2 (S6K2) in mediating proliferation signals downstream of Interleukin-3 (IL-3).
  • To determine if S6K2 activation by IL-3 is dependent on the PI-3K/mTOR pathway.

Main Methods:

  • Utilized the IL-3-dependent Ba/F3 cell line and primary mouse bone marrow-derived mast cells.
  • Assessed S6K2 activation by IL-3 stimulation.

Related Experiment Videos

  • Employed a rapamycin-resistant mutant of S6K2 (T388E) to study its function.
  • Performed cell-cycle analysis to evaluate proliferation rates.

    • Main Results:

    • IL-3 stimulation activated S6K2 in Ba/F3 cells and primary mast cells.
    • S6K2 activation was dependent on PI-3K and mTOR, but not MAPK pathway.
    • Expression of rapamycin-resistant S6K2 (T388E) enhanced IL-3-mediated proliferation.
    • T388E expression led to earlier entry into S phase, suggesting a shortened G1 phase.

    Conclusions:

    • S6 kinase 2 (S6K2) is activated by IL-3 through the PI-3K/mTOR pathway.
    • S6K2 potentiates IL-3-mediated mitogenic signals, contributing to hematopoietic cell proliferation.
    • This study provides the first evidence for S6K2's role in IL-3-dependent cell proliferation.